65,437 trials
Arthritis, Rheumatoid
Primary: Part 1: Change From Baseline Primary Soluble Inflammatory Mediators in Blood: Tumor Necrosis Factor (TNF) Alpha and Interleukin (IL) 6 for LPS Arm — 2.4086; 0.2798…
Arthritis, Juvenile Rheumatoid
Primary: Change From Baseline in DAS28-4/ESR at Week 4 — -1.01 units on a scale — p=< 0.0001
Carcinoma, Non-Small-Cell Lung
Primary: Progression-free Survival — 1.6; 3.0 months
Cognitive Decline
Primary: Proportion of Words Correctly Recognised. — 0.86; 0.85; 0.79; 0.90 proportion of words correctly recognised
Hereditary Angioedema (HAE)
Primary: Time to Onset of Symptom Relief (TOSR) — 1.75 Hours
Pediatric Obesity · Weight Loss
Primary: BMI Z-score Change — 0.01; -0.03; -0.03 z score
Facial Wrinkles · Rhytides
Primary: Improvement in Fitzpatrick Wrinkle and Elastosis Scale (FWS) Score — 51 Participants
Smoking · Smoking Cessation
Primary: Percentage of Participants With 7-Day Self-Reported Point Prevalence Abstinence — 12; 8 percentage of participants
Mastodynia
Primary: Patient Global Impression of Change (PGIC) — 55; 25 percentage of VMI/MI respondents
Skin Diseases, Infectious · Skin Diseases, Bacterial
Primary: Number of Participants With Adverse Events on Tedizolid Phosphate and Comparator Drugs — 13; 3 Participants
Diabetes
Primary: Insulin Persistence — 5.4; 4.7; 4.9 Percentage of participants
Opioid Dependence · Opioid Withdrawal
Primary: Area Under the Curve (AUC) in COWS Total Score on Days 1 to 5 Inclusive — 4.2; 3.4 Average COWS score * hours
Relapsed and Refractory Multiple Myeloma
Primary: Number of Participants With One or More Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) — 3; 3; 3; 3 Participants
Hepatitis C, Chronic
Primary: Incidence of Acute Myocardial Infarction (AMI) — 3.3; 5.2 Events per 1000 person years — p=.68
Radicular Low Back Pain
Primary: Numerical Rating Scale (0-10), an Interval Pain Scale, on Which 0 Indicates no Pain and 10 Indicates the Worst Pain Imaginable — 7.1; 5.8 units on a scale